Zhijing He

1.3k total citations
40 papers, 923 citations indexed

About

Zhijing He is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Zhijing He has authored 40 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Cancer Research. Recurrent topics in Zhijing He's work include Nanoplatforms for cancer theranostics (9 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related gene regulation (6 papers). Zhijing He is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related gene regulation (6 papers). Zhijing He collaborates with scholars based in China, United States and Hong Kong. Zhijing He's co-authors include Jianbo Ji, Guangxi Zhai, Hanjiang Wu, Xiaoye Yang, Shanghui Zhou, Yu Zhang, Zhenhu Ren, Chenping Zhang, Yun Zhu and Xiyou Du and has published in prestigious journals such as ACS Nano, Biomaterials and Brain Research.

In The Last Decade

Zhijing He

36 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhijing He China 22 352 160 158 151 137 40 923
Baozhong Shen China 14 396 1.1× 91 0.6× 259 1.6× 108 0.7× 73 0.5× 16 859
Weiqing Liu China 17 461 1.3× 78 0.5× 134 0.8× 82 0.5× 45 0.3× 43 938
Ran Yu China 14 555 1.6× 55 0.3× 177 1.1× 104 0.7× 39 0.3× 35 1.1k
Shengyun Huang China 19 444 1.3× 153 1.0× 179 1.1× 162 1.1× 70 0.5× 74 1.1k
Masao NAGUMO Japan 22 386 1.1× 56 0.3× 170 1.1× 140 0.9× 102 0.7× 94 1.3k
T Kaneda Japan 16 395 1.1× 151 0.9× 45 0.3× 199 1.3× 64 0.5× 65 1.0k
Hanwen Li China 18 326 0.9× 111 0.7× 61 0.4× 126 0.8× 47 0.3× 54 799
Shuyu Xu China 17 316 0.9× 297 1.9× 98 0.6× 44 0.3× 73 0.5× 59 832

Countries citing papers authored by Zhijing He

Since Specialization
Citations

This map shows the geographic impact of Zhijing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijing He more than expected).

Fields of papers citing papers by Zhijing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhijing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijing He. The network helps show where Zhijing He may publish in the future.

Co-authorship network of co-authors of Zhijing He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhijing He. A scholar is included among the top collaborators of Zhijing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijing He. Zhijing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhijing, Qixiang Feng, Lei Ye, et al.. (2025). A cerium-based ferroptosis/PANoptosis nano-inducer for photothermal-enhanced combination therapy of breast cancer. Chemical Engineering Journal. 516. 163961–163961.
2.
He, Zhijing, et al.. (2025). Sources of self-efficacy in career contexts: a longitudinal perspective. Current Psychology. 44(8). 7393–7403.
3.
4.
Gao, Shan, Meng Liu, Yu Zhang, et al.. (2024). A precision intelligent nanomissile for inhibiting tumor metastasis, boosting energy deprivation and immunotherapy. Biomaterials. 315. 122953–122953. 7 indexed citations
5.
Zhang, Yu, Xiyou Du, Qixiang Feng, et al.. (2024). A metabolic intervention strategy for enhanced ferroptosis/cuproptosis activation and boosted anti-tumor immunity. Chemical Engineering Journal. 500. 156732–156732. 4 indexed citations
6.
He, Zhijing, Huifeng Pi, Yi Jiang, et al.. (2024). Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux. Phytomedicine. 136. 156337–156337. 10 indexed citations
7.
He, Zhijing, He Ping Zhou, Qixiang Feng, et al.. (2023). A bimetallic dual-targeting nanoplatform for combinational ferroptosis activation/epigenetic regulation/photothermal therapy against breast cancer and tumor microenvironment remodeling. Chemical Engineering Journal. 479. 147466–147466. 7 indexed citations
8.
He, Zhijing, Yu Zhang, Dongzhu Liu, et al.. (2023). Intelligent Self-amplifying Ferroptosis-inducible nanoplatform for enhanced tumor microenvironment reconstruction and combination therapy. Chemical Engineering Journal. 468. 143729–143729. 19 indexed citations
9.
Wang, Rui, Yingying Li, Shan Gao, et al.. (2023). An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy. Biomaterials Science. 12(2). 361–374. 2 indexed citations
10.
Du, Xiyou, Zhijing He, Dongzhu Liu, et al.. (2023). A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses. European Journal of Medicinal Chemistry. 263. 115952–115952. 2 indexed citations
11.
Liu, Dongzhu, Zhijing He, Yingying Li, et al.. (2023). Biomimetic layered molybdenum oxide nanosheets with excellent photothermal property combined with chemotherapy for enhancing anti-tumor immunity. Applied Materials Today. 36. 102027–102027. 5 indexed citations
12.
Zhang, Jicheng, Yanqing Wang, Jinghui Lu, et al.. (2023). Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy. ACS Nano. 17(24). 24883–24900. 56 indexed citations
13.
Zhang, Yu, Xiyou Du, Zhijing He, et al.. (2023). A Vanadium-Based Nanoplatform Synergizing Ferroptotic-like Therapy with Glucose Metabolism Intervention for Enhanced Cancer Cell Death and Antitumor Immunity. ACS Nano. 17(12). 11537–11556. 49 indexed citations
14.
Feng, Qixiang, Yu Zhang, Zhijing He, et al.. (2022). Research progress of exosomes as drug carriers in cancer and inflammation. Journal of drug targeting. 31(4). 335–353. 6 indexed citations
15.
He, Zhijing, He Ping Zhou, Yu Zhang, et al.. (2022). Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment. Biomaterials. 290. 121832–121832. 66 indexed citations
16.
17.
Zhong, Liang, Yutong Liu, Kai Wang, et al.. (2018). Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma. BMC Cancer. 18(1). 911–911. 30 indexed citations
18.
He, Zhijing, et al.. (2017). Inhibiting ROS-NF-κB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma. Food and Chemical Toxicology. 101. 55–66. 39 indexed citations
19.
Zhou, Shanghui, Yun Zhu, Mubarak Ahmed Mashrah, et al.. (2016). Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis. Oncology Reports. 37(2). 979–985. 16 indexed citations
20.
Zhou, Shanghui, Ling Chen, Mubarak Ahmed Mashrah, et al.. (2015). Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis. OncoTargets and Therapy. 8. 2923–2923. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baozhong Shen Breakdown of academic impact, for papers by Weiqing Liu Breakdown of academic impact, for papers by Ran Yu Breakdown of academic impact, for papers by Shengyun Huang Breakdown of academic impact, for papers by Masao NAGUMO Breakdown of academic impact, for papers by T Kaneda Breakdown of academic impact, for papers by Hanwen Li Breakdown of academic impact, for papers by Shuyu Xu
Rankless by CCL
2026